who have menopausal symptoms, to get their hormone level tested and evaluate potential treatments, if needed. 4. Thyroid ...
UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...